Pfizer’s Two New R&D Heads: The Fit Is "Extraordinary”
In their first joint interview since announcing the new leadership structure of a bulked-up Pfizer, Martin Mackay and Mikael Dolsten, speak candidly about their R&D initiatives.
In their first joint interview since announcing the new leadership structure of a bulked-up Pfizer, Martin Mackay and Mikael Dolsten, speak candidly about their R&D initiatives.